NY Mets second baseman Robinson Cano has tested positive for a performance-enhancing drug. The MLB announced on Wednesday that Cano tested positive for Stanozolol and will be suspended for the entire 2021 season.
Mets president Sandy Alderson shared in a statement, “We were extremely disappointed to be informed about Robinson’s suspension for violating Major League Baseball’s Joint Drug Prevention and Treatment Program. The violation is very unfortunate for him, the organization, our fans, and the sport."
This isn’t the first time Cano has been suspended for a PED test failure. In 2018 The 38-year-old tested positive for the performance-enhancing substance furosemide as a member of the Seattle Mariners and was suspended for 80 games. Cano has spent the last two seasons with the Mets appearing in 156 games and he was expected to play a big role on the team in 2021.